title: Treatment of NASH: What Helps Beyond Weight Loss?
authors.affiliation: Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
authors.forename: Bubu A
authors.initials: BA
authors.lastname: Banini
authors.affiliation: Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
authors.forename: Arun J
authors.initials: AJ
authors.lastname: Sanyal
mesh_terms: D000428:Alcohol Drinking; D015897:Comorbidity; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D018450:Disease Progression; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008111:Liver Function Tests; D065626:Non-alcoholic Fatty Liver Disease / Q000175:diagnosis* / Q000628:therapy*; D010347:Patient Care Planning; D000077205:Pioglitazone / Q000627:therapeutic use; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors; D014810:Vitamin E / Q000627:therapeutic use; D015431:Weight Loss
chemical_list: D007004:Hypoglycemic Agents; D014810:Vitamin E; D000077205:Pioglitazone